Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Intellectual property policies in early-phase research in public-private partnerships.

Stevens H, Van Overwalle G, Van Looy B, Huys I.

Nat Biotechnol. 2016 May 6;34(5):504-10. doi: 10.1038/nbt.3562. No abstract available.

PMID:
27153280
2.

Innovative Medicines Initiative (IMI) Case Study Analysis Reveals the True Added Value of Early-Phase Public-Private Partnerships (PPPs).

Stevens H, Van Overwalle G, Van Looy B, Huys I.

Biotechnol Law Rep. 2015 Aug 1;34(4):153-165. No abstract available.

3.

The European BRCA patent oppositions and appeals: coloring inside the lines.

Matthijs G, Huys I, Van Overwalle G, Stoppa-Lyonnet D.

Nat Biotechnol. 2013 Aug;31(8):704-10. doi: 10.1038/nbt.2644. No abstract available.

PMID:
23929344
4.

The fate and future of patents on human genes and genetic diagnostic methods.

Huys I, Matthijs G, Van Overwalle G.

Nat Rev Genet. 2012 May 18;13(6):441-8. doi: 10.1038/nrg3255. Review.

PMID:
22596320
5.

Impact of gene patents on diagnostic testing: a new patent landscaping method applied to spinocerebellar ataxia.

Berthels N, Matthijs G, Van Overwalle G.

Eur J Hum Genet. 2011 Nov;19(11):1114-21. doi: 10.1038/ejhg.2011.109. Epub 2011 Aug 3.

6.

Patent pools and clearinghouses in the life sciences.

van Zimmeren E, Vanneste S, Matthijs G, Vanhaverbeke W, Van Overwalle G.

Trends Biotechnol. 2011 Nov;29(11):569-76. doi: 10.1016/j.tibtech.2011.06.002. Epub 2011 Jul 4. Review.

PMID:
21733589
7.

Gene and genetic diagnostic method patent claims: a comparison under current European and US patent law.

Huys I, Van Overwalle G, Matthijs G.

Eur J Hum Genet. 2011 Oct;19(10):1104-7. doi: 10.1038/ejhg.2011.76. Epub 2011 Jun 8.

8.

Intellectual property. Turning patent swords into shares.

Van Overwalle G.

Science. 2010 Dec 17;330(6011):1630-1. doi: 10.1126/science.1189592. No abstract available.

PMID:
21164001
9.

Legal uncertainty in the area of genetic diagnostic testing.

Huys I, Berthels N, Matthijs G, Van Overwalle G.

Nat Biotechnol. 2009 Oct;27(10):903-9. doi: 10.1038/nbt1009-903.

PMID:
19816443
10.

A clearing house for diagnostic testing: the solution to ensure access to and use of patented genetic inventions?

van Zimmeren E, Verbeure B, Matthijs G, Van Overwalle G.

Bull World Health Organ. 2006 May;84(5):352-9. Epub 2006 May 17.

11.

Patent pools and diagnostic testing.

Verbeure B, van Zimmeren E, Matthijs G, Van Overwalle G.

Trends Biotechnol. 2006 Mar;24(3):115-20. Epub 2006 Jan 27. Review.

PMID:
16443296
12.

Models for facilitating access to patents on genetic inventions.

Van Overwalle G, van Zimmeren E, Verbeure B, Matthijs G.

Nat Rev Genet. 2006 Feb;7(2):143-8. doi: 10.1038/nrg1765. Review.

PMID:
16385347
13.

Analysing DNA patents in relation with diagnostic genetic testing.

Verbeure B, Matthijs G, Van Overwalle G.

Eur J Hum Genet. 2006 Jan;14(1):26-33.

14.

Bio-patents, law and ethics. Critical analysis of the EU biotechnology directive.

Van Overwalle G.

Rev Derecho Genoma Hum. 2003 Jul-Dec;(19):187-203. Review. No abstract available.

PMID:
15032104

Supplemental Content

Loading ...
Support Center